Literature DB >> 23514991

Myeloma and thrombotic complications.

I Tzoran1, B Brenner, R Hoffman.   

Abstract

Multiple myeloma (MM) is a hematological malignancy with high risk for thrombosis. While venous thromboembolism is more common, myeloma patients can also present with arterial thrombosis. Risk factors responsible for this complication can be patient-related, myeloma- and treatment-related. Thromboprophylaxis is indicated along with specific therapeutic regimens employed in myeloma patients. This review will cover potential risk factors for thrombosis in patients with multiple myeloma, prevention recommendations and treatment strategies in this clinical setting.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23514991

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  1 in total

1.  Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States.

Authors:  Daniel Auclair; Carol Mansfield; Mark A Fiala; Ajai Chari; Craig E Cole; Jonathan L Kaufman; Gregory J Orloff; David S Siegel; Jeffrey A Zonder; Brennan Mange; Jennifer Yesil; Mehul Dalal; Joseph R Mikhael
Journal:  Patient Prefer Adherence       Date:  2022-03-01       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.